NEWS ABOUT US EXPERIENCE STRATEGY TEAM PORTFOLIO CONTACT US

c
 

NEWS

2014 | 2013 | 2012 | 2011 | 2009

 

 

 


NinePoint Medical
December 13, 2010 - NinePoint Medical Seals Big Licensing Deal with Massachusetts General Hospital
Press Release | Company News


ROXRO Pharma
December 13, 2010 - Luitpold Pharmaceuticals Acquires ROXRO PHARMA, Inc., a U.S. Company Developing Accute Pain Products
Press Release


Infinity Pharmaceuticals
December 13, 2010 - Infinity and Mundipharma Extend Global Strategic Alliance
Press Release | Company News


Insmed
December 2, 2010 - Insmed Incorporated and Transave, Inc. Announce Business Combination
Press Release | Company News


Aveo Pharmaceuticals
December 1, 2010 - OSI Pharmaceuticals, Inc. Exercises Option under Discovery and Translational Research Collaboration with AVEO
Press Release | Company News


Complete Genomics
November 11, 2010 - Complete Genomics Announces Pricing of Initial Public Offering
Press Release | Company News


Aveo Pharmaceuticals
November 3, 2010 - AVEO Pharmaceuticals' Tivozanib Recognized as One of Windhover's 2011 Top 10 Oncology Projects to Watch
Press Release | Company News


Hansen Medical
November 1, 2010 - U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of Hansen Medical Sensei(R) X Robotic Catheter System for Treatment of Atrial Fibrillation
Press Release | Company News


Aveo Pharmaceuticals
October 29, 2010 - AVEO Pharmaceuticals Announces $61 Million Private Placement
Press Release | Company News


Amicus Therapeutics
October 29, 2010 - GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal(TM) for Fabry Disease
Press Release | Company News


Emergent BioSolutions
October 28, 2010 - Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
Press Release | Company News


Amira Pharmaceuticals
October 28, 2010 - Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist, Potential Therapy for Lung Fibrosis of Scleroderma and Idiopathic Pulmonary Fibrosis
Press Release | Company News


Infinity Pharmaceuticals
October 26, 2010 - Infinity Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Ltd. Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
Press Release | Company News


NinePoint Medical
October 14, 2010 - NinePoint Medical Raises $33M A Round to Develop New Diagnostic Devices
Press Release | Company News


NGM Biopharmaceuticals
October 5, 2010 - NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
Press Release | Company News


Baxano, Inc.
October 4, 2010 - Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards
Press Release | Company News


Hansen Medical
October 4, 2010 - Hansen Medical Announces First Patients Successfully Treated With New Flexible Catheter Vascular Robotic System
Press Release | Company News


DFine
October 4, 2010 - DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions
Press Release | Company News


Aveo Pharmaceuticals
September 30, 2010 - AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-299
Press Release | Company News


Portola Pharmaceuticals
September 23, 2010 - Portola Pharmaceuticals Appoints Jean-Jacques Bienaimé to Board of Directors
Press Release | Company News


Topica Pharmaceuticals
September 21, 2010 - TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
Press Release | Company News


Amira Pharmaceuticals
September 15, 2010 - Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotech’s Annual Fierce 15
Press Release | Company News


Kythera Biopharmaceuticals
September 1, 2010 - Will Kythera Biopharma's ATX 101 be the Next Botox?
Press Release | Media Coverage


Amira Pharmaceuticals
September, 2010 - Amira Pharmaceuticals: Creating High Value Compounds
Press Release | Media Coverage


Kythera Biopharmaceuticals
August 30, 2010 - Kythera and Bayer Dermatology Unit Intendis Enter Licensing and Development Agreement for Adipolytic Agent ATX-101
Press Release | Company News


Portola Pharmaceuticals
August 30, 2010 - Portola Pharmaceuticals Announces that Phase 2 INNOVATE-PCI Trial with Elinogrel Achieved Objectives
Press Release | Company News


Amicus Therapeutics
August 5, 2010 - Amicus Therapeutics Announces Continued Progress on Global Phase 3 Program for Fabry Disease and Second Quarter 2010 Financial Results
Press Release | Company News


Amicus Therapeutics
July 21, 2010 - Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
Press Release | Company News


Amira Pharmaceuticals
July 19, 2010 - Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program
Press Release | Company News


DFine
July 7, 2010 - DFine, Inc. Announces Close of $36 Million Funding
Press Release | Company News


Lux Biosciences
July 1, 2010 - Lux Biosciences Names Dean Mitchell President and CEO
Press Release | Company News


Vitae Pharmaceuticals
June 29, 2010 - Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
Press Release | Company News


Baxano, Inc.

June 22, 2010 - Baxano, Inc. Announces Close of $30 Million Series C Funding
Press Release> | Company News


Novavax
April 29, 2010 - Novavax’s Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
Press Release | Company News


Hansen Medical
April 29, 2010 - Studies Show Increased Safety and Substantial Reduction in Harmful Radiation to Patient With Sensei Robotic System
Press Release | Company News


Aveo Pharmaceuticals
April 1, 2010 - AVEO Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option for Recent Initial Public Offering
Press Release | Company News


Aveo Pharmaceuticals
March 18, 2010 - AVEO Pharmaceuticals, Inc. Completes Initial Public Offering
Press Release | Company News


NGM Biopharmaceuticals
March 15, 2010 - NGM Biopharmaceuticals Raises $51M in Series B Financing and Appoints New Board Member
Press Release | Company News


Lux Biosciences
March 2, 2010 - Lux Biosciences Receives Acceptance of Luveniq™ MAA Filing from European Medicines Agency
Press Release | Company News


Amira Pharmaceuticals
January 28, 2010 - Amira Mixes Small Biotech Irreverence, With Big Pharma Rigor, To Create New Lung Drugs
Press Release | Media Coverage


Gloucester Pharmaceuticals
January 15, 2010 - Celgene Completes Acquisition of Gloucester Pharmaceuticals
Press Release

 

News Archives